During the pandemic, dermatologists faced a number of issues with trying to keep physical distancing protocols while providing adequate care for suspected skin cancers. John Dobak, MD, discusses how a novel, noninvasive patch and genomic test, the pigmented lesion assay, can help diagnose melanoma through teledermatology.
Disclosure: Dr Dobak is the chief executive officer of DermTech, Inc, the manufacturer of the PLA.
